IAG Wealth Partners’s Amedisys AMED Stock Holding History

IAG Wealth Partners’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13	Closed	-$3K	–	356
2020 Q2	$3K	Hold	13	–	–	﹤0.01%	304
2020 Q1	$3K	Hold	13	–	–	﹤0.01%	296
2019 Q4	$3K	Buy	+13	New	+$1.93K	﹤0.01%	334

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IAG Wealth Partners's AMED Position: Q3 2020 in Review

IAG Wealth Partners sold out of Amedisys (AMED) in Q3 2020, closing a stake of 13 shares — an estimated $3K sold.

IAG Wealth Partners first reported a position in AMED in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q2 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

IAG Wealth Partners reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
IAG Wealth Partners sold 13 Amedisys shares in Q3 2020, an estimated $3K.
IAG Wealth Partners first reported a position in Amedisys in Q4 2019 and held it in 3 quarters.
IAG Wealth Partners's Amedisys position peaked at $3K in Q2 2020.
397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on IAG Wealth Partners's 13F filing for Q3 2020, filed 11 Feb 2021.